Tuesday, November 28, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Infectious Emerging Diseases

New insights into uncontrolled inflammation in COVID-19 patients

July 22, 2021
in Infectious Emerging Diseases
0
Share on FacebookShare on Twitter

Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients

In a new study, published recently in the journal Circulation Research, scientists discover how the production of protective molecules known as specialised pro-resolving mediators (SPM) is altered in patients with COVID-19.

The results suggest that treatments which increase SPM production, such as dexamethasone or SPM based drugs, could play a key role in limiting inflammation in these patients.

Currently there is little understanding around the mechanisms that lead to uncontrolled inflammation in patients with COVID-19.

The study found a link between decreased SPM blood levels and disrupted white blood cell responses in patients with a higher disease burden. The findings also revealed that dexamethasone, the first drug approved for treatment of patients with COVID-19, increased the levels of these protective molecules in these patients. Furthermore, treatment of white blood cells with SPM improved their function and reduced the expression of molecules linked to the spread of inflammation. Understanding these mechanisms will help provide new leads into the development of treatments to limit disease severity in patients with COVID-19.

This study offers a new insight into the disrupted biological processes that contribute to increased disease severity in COVID-19 patients. Results suggest that treatments which increase SPM production, such as dexamethasone or SPM based drugs, could play a key role in limiting inflammation in this patient group.

Jesmond Dalli, Professor in Molecular Pharmacology and Lipid Mediator Unit Director at Queen Mary University of London said: “The observation that dexamethasone increased the production of SPM was a surprising finding. This finding suggests that SPM may serve as biomarkers to determine the efficacy of this drug in limiting inflammation in patients with COVID-19. Another surprising finding was that blood levels of these molecules remained altered several weeks after resolution of clinical symptoms.”

“Our results are the first to relate the impact that COVID-19 infections on immune responses and to explore the utility of using SPM to rectify white blood cell behaviour. Given the extensive body of literature demonstrating the protective role of these molecules in limiting inflammation in both viral and bacterial infections these results suggest that SPM and SPM-based therapeutics may be useful in the treatment of infections to limit inflammation without compromising the ability of the immune system to deal with the invading pathogen”.

Mauro Perretti (Dean for Research, School of Medicine and Dentistry) said: “This study is a perfect example of a productive partnership between Barts and the London School of Medicine at Queen Mary and Barts NHS Trust, a partnership established in difficult circumstances yet successful thanks to the will and commitment of our scientists and clinicians. The paper presents world class data on how resolution pathways impact on COVID infection, opening opportunities for new therapies and new markers to predict patient outcome”.

###

Further information

* Research paper: “Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in Covid-19”. Circulation Research. https://doi.org/10.1161/CIRCRESAHA.121.319142

Media Contact
Joel Winston
j.winston@qmul.ac.uk
http://dx.doi.org/10.1161/CIRCRESAHA.121.319142

Tags: CardiologyInfectious/Emerging DiseasesMedicine/Health
Share26Tweet16Share4ShareSendShare
  • Collaboration between women helps close the gender gap in ice core science

    71 shares
    Share 28 Tweet 18
  • Vampire bats make northward flight seeking stable climates

    65 shares
    Share 26 Tweet 16
  • Top ERC funding in the millions for four researchers

    65 shares
    Share 26 Tweet 16
  • Giant sea salt aerosols play major role in Hawai‘i’s coastal clouds, rain

    65 shares
    Share 26 Tweet 16
  • Mining industry competing with salmon for rivers created by disappearing glaciers: SFU study finds

    65 shares
    Share 26 Tweet 16
  • Pay transparency may be good for employees but bad for companies in a downturn

    65 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Alcohol consumption and epigenetic age acceleration across human adulthood

Trilobites rise from the ashes to reveal ancient map

“Amaterasu” particle: a new cosmic mystery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In